M. Benson

发表

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

A. Pantuck, A. Pantuck, M. Benson, 1992, The Journal of urology.

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

M. Benson, I. S. Whang, C. Olsson, 1992, The Journal of urology.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Cyriac Kandoth, Mitchell C. Benson, Jonathan A. Coleman, 2018, Cell.

Predicting the clinical course of prostate cancer.

J. McKiernan, M. Benson, 2004, The Journal of clinical investigation.

The immune response to AIDS virus infection : good , bad , or both ?

J. McKiernan, M. Benson, 2022 .

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

C. Tangen, E. Crawford, C. Moinpour, 2004, The New England journal of medicine.

Association of estimated glomerular filtration rate (eGFR) with odds of a renal lesion.

M. Desai, J. McKiernan, M. Benson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin.

I. Thompson, C. Tangen, W. Sakr, 2013, The Journal of urology.

Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residents.

Jaime Landman, Joseph A. Graversen, Adam C. Mues, 2011, Urology.

Enhanced reverse transcriptase‐polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer

M. Benson, C. Olsson, M. Begg, 1995, Cancer.

Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase‐polymerase chain reaction assay in patients with early stage prostate carcinoma

M. Rubin, D. Heitjan, M. Benson, 1997, Cancer.

Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.

M. Benson, C. Olsson, S. Wenske, 2013, Urology.

Urinary continence after radical prostatectomy: the Columbia experience.

D. Heitjan, M. Benson, C. Olsson, 1998, The Journal of urology.

Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.

P. Pierorazio, J. McKiernan, M. Benson, 2007, Urology.

Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years.

Adam C. Mues, K. Badani, J. McKiernan, 2011, Urology.

Toward objective prognostic grading of prostatic carcinoma using image analysis.

J P Rigaut, J. Rigaut, M. Benson, 1993, Analytical and quantitative cytology and histology.

Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter.

M. Benson, C. Olsson, I. Sawczuk, 1987, The Journal of urology.

Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell death

M. Benson, C. Olsson, P. Tomashefsky, 1988, The Prostate.

Society of Urologic Oncology position statement: Redefining the management of hormone‐refractory prostate carcinoma

Sam S. Chang, C. Higano, M. Benson, 2005, Cancer.

Erythropoietin-induced optimization of renal function after warm ischemia.

M. Benson, G. Hruby, G. Mirabile, 2009, Journal of endourology.

Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.

L. Salomon, J. McKiernan, M. Benson, 2003, Urology.

Flow cytometric analysis of localized adenocarcinoma of the prostate: The use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy

M. Benson, K. Ring, C. Olsson, 1990, The Prostate.

The application of perpendicular and forward light scatter to assess nuclear and cellular morphology.

D. S. Coffey, M. Benson, D. C. McDougal, 1984, Cytometry.

The use of multiparameter flow cytometry to assess tumor cell heterogeneity and grade prostate cancer

D. S. Coffey, M. Benson, D. C. McDougal, 1984, The Prostate.

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

M. Benson, C. Olsson, A. Raffo, 1996, The Journal of urology.

Molecular staging of genitourinary malignancies.

M. Benson, C. Olsson, R. Buttyan, 1996, Urology.

The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy.

M. Rubin, M. Stifelman, M. Benson, 1996, The Urologic clinics of North America.

Improved continence with tubularized bladder neck reconstruction following radical retropubic prostatectomy.

M. Benson, E. Seaman, 1996, Urology.

Molecular Stating of Prostate Cancer. II. A Comparison of the Application of an Enhanced Reverse Transcriptase Polymerase Chain Reaction Assay for Prostate Specific Antigen Versus Prostate Specific Membrane Antigen

M. Benson, C. Olsson, D. McMahon, 1995 .

Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.

J. McKiernan, M. Benson, P. Gorroochurn, 2009, Journal of the Society for Integrative Oncology.

Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells

M. Benson, M. Burchardt, R. Buttyan, 2003, The Prostate.

Urologic aspects of andropause.

M. Benson, A. Anastasiadis, R. Shabsigh, 2003, Urology.

Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.

J. McKiernan, M. Benson, C. Anderson, 2021, Urologic oncology.

Preoperative Antibiotics Before Bladder Biopsy: Are They Necessary?

M. Benson, Marissa C. Theofanides, K. Cooper, 2017, Urology.

Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer?

M. Desai, J. Lam, M. Mansukhani, 2004, The Journal of urology.

Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.

J. McKiernan, M. Benson, C. Olsson, 2007, Urology.

Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.

K. Badani, J. McKiernan, M. Benson, 2015, Urology.

THE ROLE OF THE REVERSE- TRANSCRIPTASE POLYMERASE CHAIN REACTION ASSAY FOR THE SELECTION OF PATIENTS FOR RADICAL PROSTATECTOMY PROSTATE-SPECIFIC ANTIGEN IN

M. Rubin, M. Stifelman, M. Benson, 1996 .

Has the advent of minimally invasive surgery altered the risk profile of patients undergoing prostatectomy?

K. Badani, J. McKiernan, M. Benson, 2010, Urology.

Robot-assisted radical cystoprostatectomy in complex surgical patients: single institution report.

K. Badani, J. McKiernan, M. Benson, 2009, The Canadian journal of urology.

Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys

J. McKiernan, M. Benson, G. Hruby, 2011, World Journal of Urology.

Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.

J. McKiernan, M. Benson, L. Barlow, 2010, Urology.

Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer.

J. McKiernan, M. Benson, C. Deibert, 2014, Urologic oncology.

Acupuncture and Moxibustion for Side Effects of Chemotherapy in Cancer Patients

M. Benson, D. Hershman, J. Capodice, 2012 .

Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.

D. R. Knowles, A. Shabsigh, M. Benson, 2003, Urology.

PSA density (PSAD). Role in patient evaluation and management.

M. Benson, C. Olsson, W. Cooner, 1993, The Urologic clinics of North America.

Editorial comment.

M. Benson, 2010, The Journal of urology.

Fine-needle aspiration of the prostate.

M. Benson, 1988, NCI monographs : a publication of the National Cancer Institute.

Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?

M. Desai, J. Lam, M. Mansukhani, 2003, The Journal of urology.

Does the Number of Lymph Nodes Removed During Radical Prostatectomy Impact Risk of Biochemical Recurrence in Patients With Isolated Seminal Vesicle Invasion ?

K. Badani, J. McKiernan, M. Benson, 2016 .

Clinical Science : First Prize ( Tie ) Laparoscopic Renal Cryoablation : Efficacy and Complications for Larger Renal Masses

J. McKiernan, M. Benson, G. Hruby, 2009 .

Gender discrepancies in the diagnosis of renal cortical tumors

P. Pierorazio, J. McKiernan, M. Benson, 2007, World Journal of Urology.

The evolving role of partial nephrectomy in the management of renal cell carcinoma

P. Russo, J. McKiernan, M. Benson, 2003, Current oncology reports.

Oncologic Outcomes of Definitive Treatments for Low‐ and Intermediate‐Risk Prostate Cancer After a Period of Active Surveillance

J. McKiernan, M. Benson, J. Matulay, 2017, Clinical genitourinary cancer.

Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer.

J. Heymann, M. Mansukhani, M. Benson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Editorial: Prostate Specific Antigen

M. Benson, 1997 .

New Techniques in Management and Treatment of Superficial Bladder Cancer

M. Benson, J. Franklin, 1994 .

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

M. Benson, C. Olsson, P. Schiff, 2003, Urology.

Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer.

D. Bostwick, H. Lilja, A. Semjonow, 1999, Seminars in urologic oncology.

Robot-assisted radical cystoprostatectomy in the post-radiation and chemotherapy patient

K. Badani, M. Benson, G. Joel Decastro, 2008, Journal of robotic surgery.

Effect of statin use on biochemical outcome following radical prostatectomy

K. Badani, J. McKiernan, M. Benson, 2011, BJU international.

Flow cytometric determination of the multidrug resistant phenotype in transitional cell cancer of the bladder: implications and applications.

M. Benson, I. S. Whang, C. Olsson, 1991, The Journal of urology.

Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.

M. Benson, D. Peehl, R. Buttyan, 2000, Urology.

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer.

D. Heitjan, M. Benson, C. Olsson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer: preliminary results.

P. Walsh, M. Benson, 1986, Journal of Urology.

The role of intravenous zoledronic acid in the management of high-risk prostate cancer

J. McKiernan, M. Benson, C. Olsson, 2003, Current opinion in urology.

Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.

E. H. Lambert, P. Pierorazio, J. McKiernan, 2007, Urology.

Androgen-dependent Shionogi Mouse Mammary Carcinoma Gene Expression during the Early Phases of Regression of the Updated

N. Bruchovsky, M. Benson, R. Buttyan, 2006 .

Gene Expression during the Early Phases of Regression of the Androgen-dependent Shionogi Mouse Mammary Carcinoma 1

N. Bruchovsky, M. Benson, R. Buttyan, 2006 .

A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

D. Chopin, S. Terry, M. Benson, 2005, Cancer research.

Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.

L. Salomon, J. McKiernan, M. Benson, 2004, Urologic oncology.

The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.

M. Benson, C. Olsson, D. Petrylak, 2000, The Journal of urology.

Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance.

J. McKiernan, M. Benson, J. RiChard, 2012, Urology.

Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools.

A. Roychoudhury, J. McKiernan, M. Benson, 2015, Urologic oncology.

Muscle-invasive urothelial carcinoma of the bladder.

M. Benson, S. Malkowicz, V. Pansadoro, 2007, Urology.

A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy.

M. Benson, H. Rashid, E. Bagiella, 2000, The Journal of urology.

Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer.

M. Benson, C. Olsson, J. Newhouse, 1999, Seminars in oncology.

Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern.

M. Benson, C. Olsson, J. Connor, 1989, Urology.

Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms.

Adam C. Mues, K. Badani, J. McKiernan, 2010, Urology.

The use of video-based patient education for shared decision-making in the treatment of prostate cancer.

J. Forman, M. Benson, M. Soloway, 2000, Seminars in urologic oncology.

Rat Prostate Regrowth Gene Activity during the Early Phase of Androgen-stimulated Updated Version

M. Benson, C. Olsson, P. Tomashefsky, 2006 .

The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.

J. McKiernan, M. Benson, L. Barlow, 2016, The Journal of urology.

The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

E. H. Lambert, P. Pierorazio, J. McKiernan, 2007, BJU international.

Prospective comparison of flexible fiberoptic and digital cystoscopes.

M. Benson, F. Marruffo, Mantu Gupta, 2009, Urology.

Comparison of Original and Internal Pathology Reports Referred for UrothelialCarcinoma to Determine Rate of Discrepancies and the Impact on Treatment Decisions

M. Benson, L. Barlow, Edan Y. Shapiro, 2017 .

Adult Urology reoperative Risk Stratification Predicts ikelihood of Concurrent PSA-Free Survival, ontinence, and Potency (the Trifecta nalysis) After Radical Retropubic rostatectomy

J. McKiernan, M. Benson, B. Spencer, 2007 .

Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible

L. Salomon, J. McKiernan, M. Benson, 2003, Prostate Cancer and Prostatic Diseases.

Original Articles PREOPERATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION FOR PROSTATE SPECIFIC ANTIGEN PREDICTS TREATMENT FAILURE FOLLOWING RADICAL PROSTATECTOMY

M. Benson, C. Olsson, A. Raffo, 1996 .

Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy.

D. Heitjan, M. Benson, C. Olsson, 1997, The Journal of urology.

The role of tumor biomarkers as predictors of serum PSA recurrence after radical prostatectomy.

M. Benson, A. De la taille, R. Buttyan, 1998, Seminars in urologic oncology.

Gene activity during the early phase of androgen-stimulated rat prostate regrowth.

M. Benson, C. Olsson, P. Tomashefsky, 1989, Cancer research.

The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy

M. Desai, K. Badani, D. S. Berkman, 2009, BJU international.

Contemporary experience in the management of angiomyolipoma.

Adam C. Mues, K. Badani, J. McKiernan, 2010, Journal of endourology.

Acupuncture for the Treatment of Hot Flashes in Men with Advanced Prostate Cancer

J. McKiernan, M. Benson, J. Capodice, 2011 .

Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

M. Desai, J. McKiernan, M. Benson, 2006 .

Prostate specific antigen screening.

J. McKiernan, M. Benson, 2007, The Journal of urology.

The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy

J. McKiernan, M. Benson, L. Barlow, 2009, BJU international.

Lessons Learned from Routine Intraoperative Ureteral Margin Frozen Sections during Radical Cystectomy

J. McKiernan, M. Benson, A. Nieder, 2015 .

Partial Cystectomy for Primary Bladder Tumors in Contemporary Patients with Diverse Tumor Locations

J. McKiernan, M. Benson, D. Lascano, 2016 .

Prostate cancer in men less than 45 years old: influence of stage, grade and therapy.

M. Benson, S. Kaplan, C. Olsson, 1987, The Journal of urology.

Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure.

A. Roychoudhury, J. McKiernan, M. Benson, 2014, The Journal of urology.

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin.

P. Carroll, W. Ellis, A. Belldegrun, 1998, Urology.

The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder.

J. McKiernan, M. Benson, G. Hruby, 2014, The Journal of urology.

Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG.

J. McKiernan, M. Benson, L. Barlow, 2010, Urologic oncology.

Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed

P. Pierorazio, J. McKiernan, M. Benson, 2007, BJU international.

High‐grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy

P. Pierorazio, J. McKiernan, M. Benson, 2007, BJU international.

Cutaneous Continent Urinary Diversion

J. McKiernan, M. Benson, G. Decastro, 2012 .

External beam radiation therapy does not offer long-term control of prostate cancer.

M. Benson, M C Benson, E T Goluboff, 1996, The Urologic clinics of North America.

Predictive value of prostate-specific antigen density for the presence of micrometastatic carcinoma of the prostate.

M. Benson, I. S. Whang, C. Olsson, 1994, Urology.

Prostate-specific antigen density: a new prognostic indicator for prostate cancer.

M. Benson, D. McMahon, P. Schiff, 1993, International journal of radiation oncology, biology, physics.

Retrograde Urinary Drainage: A Combined Approach

M. Benson, E. Martin, K. Laffey, 1987 .

Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.

J. Lam, M. Benson, M. O'Donnell, 2003, Urologic oncology.

Role of DNA and specific cytoplasmic receptors in glucocorticoid action.

M. Benson, J. Baxter, R. Garcea, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Single luminal epithelial progenitors can generate prostate organoids in culture

K. Badani, J. McKiernan, M. Benson, 2014, Nature Cell Biology.

The flow cytometric analysis of undescended testes in children.

M. Benson, K. Ring, T. Hensle, 1990, The Journal of urology.

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

D. Chopin, M. Colombel, M. Benson, 1993, The American journal of pathology.

Current concepts in biomarker technology for bladder cancers.

A. Shabsigh, M. Benson, A. De la taille, 2000, Clinical chemistry.

Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma.

K. Badani, M. Benson, S. Poon, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers

J D Siegal, M. Benson, C. Olsson, 1988, The Prostate.

Bropirimine immunotherapy of upper urinary tract carcinoma in situ.

P. Carroll, P. Schellhammer, D. Lamm, 1996, Urology.

A report of cytomegalovirus cystitis and a review of other genitourinary manifestations of the acquired immune deficiency syndrome.

M. Benson, K. O'toole, M. Romagnoli, 1988, The Journal of urology.

A Molecular Signature Predictive of Indolent Prostate Cancer

Andrea Califano, Pavel Sumazin, Mukesh Bansal, 2013, Science Translational Medicine.

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

James T. Lin, K. Badani, J. McKiernan, 2016, PloS one.

Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men.

M. Desai, K. Badani, J. McKiernan, 2009, Urology.

How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?

M. Desai, J. McKiernan, M. Benson, 2009, BJU international.

The relationship between preoperative prostate‐specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome

M. Desai, P. Pierorazio, J. McKiernan, 2009, BJU international.

Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.

J. McKiernan, M. Benson, R. Korets, 2008, Urology.

Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy.

P. Pierorazio, J. McKiernan, M. Benson, 2007, Urology.

Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer.

M. Desai, M. Mansukhani, J. McKiernan, 2007, Urology.

Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy.

M. Desai, J. McKiernan, M. Benson, 2006, The Journal of urology.

The evaluation and staging of clinically localized prostate cancer

J. McKiernan, M. Benson, M. Katz, 2005, Nature Clinical Practice Urology.

Prostate Cancer as the Advent of Minimally nvasive Surgery Altered the Risk Profile f Patients Undergoing Prostatectomy ?

K. Badani, M. Benson, M. Mann, 2022 .

Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes

K. Badani, J. McKiernan, M. Benson, 2014, Prostate Cancer and Prostatic Disease.

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

J. McKiernan, M. Benson, R. Santella, 2012, The Prostate.

Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy.

J. McKiernan, M. Benson, L. Barlow, 2013, The Journal of urology.

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

M. Benson, C. Olsson, D. McMahon, 1994, Urology.

Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer

M. Benson, L. Barlow, 2013, Current Urology Reports.

Simultaneous multiple double pigtail stents for malignant ureteral obstruction.

A. Shabsigh, M. Benson, D. Fromer, 2002, Urology.

Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome

J. McKiernan, M. Benson, T. Schubert, 2015, World Journal of Urology.

Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.

M. Mansukhani, J. McKiernan, M. Benson, 2006, Urology.

Ureteral reconstruction and bypass: experience with ileal interposition, the Boari flap-psoas hitch and renal autotransplantation.

M. Benson, K. Ring, C. Olsson, 1990, The Journal of urology.

Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.

M. Mansukhani, M. Benson, P. Schiff, 2007, Urology.

Improved Biochemical Control and Clinical Disease‐Free Survival with Intraoperative Versus Preoperative Preplanning for Transperineal Interstitial Permanent Prostate Brachytherapy

M. Benson, C. Wuu, A. Katz, 2006, Cancer journal.

Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer.

I. Hsu, M. Benson, M. Begg, 1997, Urology.

MRI of multilocular cystic nephroma

M. Benson, J. Newhouse, L. Sanders, 1988, Urologic radiology.

Analysis of continent versus standard urinary diversion.

M. Benson, C. Olsson, K. Slawin, 1992, British journal of urology.

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.

P. Schellhammer, C. Tangen, A. Sagalowsky, 2005, Urologic oncology.

Continent urinary diversion.

M. Benson, C. Olsson, 1984, The Urologic clinics of North America.

Pathological tumour diameter predicts risk of conventional subtype in small renal cortical tumours

M. Desai, J. McKiernan, M. Benson, 2008, BJU international.

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

C. Cordon-Cardo, M. Benson, R. Rodríguez-Barrueco, 2012, Cancer cell.

Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult.

M. Desai, M. Mansukhani, J. McKiernan, 2004, Urology.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

P. Kantoff, M. Cooperberg, T. Rebbeck, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

C. Tangen, E. Crawford, D. Ankerst, 2006, Journal of the National Cancer Institute.

Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma.

N. Bruchovsky, M. Benson, P. Rennie, 1988, Cancer research.

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

A. Neugut, M. Rubin, M. Benson, 1999, Urology.

Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.

M. Benson, C. Olsson, J. Newhouse, 2000, The Journal of urology.

The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy.

M. Benson, C. Olsson, K. O'toole, 1995, The Journal of urology.

Epidural cord compression in association with genitourinary neoplasms

M. Benson, E. Housepian, C. H. Chang, 1986, Cancer.

A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy.

A. Roychoudhury, J. McKiernan, M. Benson, 2016, Urology.

A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer.

J. McKiernan, M. Benson, D. Petrylak, 2011, The Journal of urology.

Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy

K. Badani, A. Roychoudhury, J. McKiernan, 2016, The Prostate.

An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density

M. Benson, C. Olsson, W. Cooner, 2004, World Journal of Urology.

Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management

M. Benson, C. Olsson, 1994, Cancer.

A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival.

M. Mansukhani, J. McKiernan, M. Benson, 2004, Urologic oncology.

Original article A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: morbidity and long-term survival

M. Mansukhani, J. McKiernan, M. Benson, 2004 .

Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.

J. McKiernan, M. Benson, C. Olsson, 2006, Urology.

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.

M. Benson, C. Olsson, D. McMahon, 1995, The Journal of urology.

The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience

J. McKiernan, M. Benson, L. Barlow, 2009, World Journal of Urology.

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells

S. Terry, M. Benson, Yinglu Guo, 2006, Oncogene.

Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.

A. Roychoudhury, J. McKiernan, M. Benson, 2012, Urology.

Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy.

C. Drake, J. McKiernan, M. Benson, 2018, Urology.

Bladder preservation for patients with bladder paragangliomas: case series and review of the literature.

J. McKiernan, M. Benson, R. Virk, 2020, Urology.

Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.

J. McKiernan, M. Benson, Edan Y. Shapiro, 2012, Journal of endourology.

The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.

M. Benson, K. Ring, C. Olsson, 1992, The Journal of urology.

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2‐T4aN0‐N2M0 bladder cancer

C. Cordon-Cardo, M. Mansukhani, J. McKiernan, 2012, Cancer.

The first assistant sparing technique robot-assisted partial nephrectomy decreases warm ischemia time while maintaining good perioperative outcomes.

K. Badani, M. Benson, C. Wambi, 2012, Journal of endourology.

The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer.

M. Benson, C. Olsson, A. Raffo, 1996, British journal of urology.

Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger.

J. McKiernan, M. Benson, C. Olsson, 2006, Urology.

Arteriovenous malformation of ureter.

M. Benson, S. Kaplan, K. O'toole, 1992, Urology.

Large multilocular Müllerian duct cyst presenting as pelvic mass.

M. Benson, S. Gilbert, G. Decastro, 2004, Urology.

Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer

A. Neugut, M. Benson, B. Insel, 2013, Supportive Care in Cancer.

Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades.

J. McKiernan, M. Benson, A. Murphy, 2009, Urology.

Giant multilocular cystadenoma of the prostate.

M. Benson, H. Hibshoosh, A. Kirsch, 1996, Urology.

Bilateral intrarenal adrenal glands in cadaveric donor kidneys resembling renal cell carcinoma on intraoperative frozen section.

M. Benson, A. Benvenisty, M. Hardy, 2001, The Journal of urology.

Comparison of distal ureteral management strategies during laparoscopic nephroureterectomy.

Adam C. Mues, J. McKiernan, M. Benson, 2011, Journal of endourology.

Erratum to ‘Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles’[Urol Oncol 22 (2004) 107–111]

L. Salomon, J. McKiernan, M. Benson, 2004 .

Postprostatectomy Salvage Radiation Therapy for Prostate Cancer: Impact of Pathological and Biochemical Variables and Prostate Fossa Biopsy

M. Benson, C. Olsson, P. Schiff, 2002, Cancer journal.

From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience

Mitchell C. Benson, M. Benson, D. Samadi, 2007, World Journal of Urology.

Urologic manifestations of AIDS.

M. Benson, M. S. Kaplan, M. Wechsler, 1987, Urology.

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.

M. Kattan, A. Kibel, A. Partin, 2007, The Journal of urology.

ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer.

C. Cordon-Cardo, F. Algaba, M. Benson, 2015, Journal of Urology.

Safety of the antimyostatin monoclonal antibody LY2495655 in healthy subjects and patients with advanced cancer.

David A. Smith, M. Benson, G. Weiss, 2012 .

Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy.

Joseph A. Graversen, K. Badani, J. McKiernan, 2011, Journal of endourology.

Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?

J. McKiernan, M. Benson, G. Hruby, 2012, BJU international.

SUTURELESS VESICO-URETHRAL ANASTOMOSIS AFTER RADICAL PROSTATECTOMY: INITIAL CLINICAL FEASIBILITY DATA FROM THE CONTINUUM STUDY

A. Moinzadeh, I. Tuerk, M. Benson, 2008 .

The ileal ureter neobladder is associated with a high success and a low complication rate.

M. Benson, C. Olsson, E. Seaman, 1997, The Journal of urology.

Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes

K. Badani, A. Roychoudhury, J. McKiernan, 2015, The Prostate.

Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis

J. McKiernan, M. Benson, G. Hruby, 2012, BJU international.

Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer.

A. Neugut, M. Benson, R. McBride, 2013, Journal of oncology practice.

A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies

J. McKiernan, M. Benson, M. Laudano, 2008, World Journal of Urology.

Predicting Renal Parenchymal Loss after Nephron Sparing Surgery.

A. Weinberg, P. Pierorazio, J. McKiernan, 2015, The Journal of urology.

A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard.

Tian Liu, Jun Zhou, Pengpeng Zhang, 2009, Medical physics.

Blood‐based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow‐up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy

D. Chopin, M. Benson, C. Olsson, 1999, International journal of cancer.

Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.

M. Benson, C. Olsson, A. De la taille, 2001, The Journal of urology.

1461: Local Control and Long Term Disease Free Survival Following Radical Prostatectomy for D1 Prostate Cancer In The PSA ERA

J. McKiernan, M. Benson, C. Olsson, 2004 .

Multiple primary neoplasms in association with prostate cancer in black and white patients

A. Neugut, M. Benson, C. Olsson, 1987, Cancer.

Heparin prophylaxis and the risk of venous thromboembolism after robotic‐assisted laparoscopic prostatectomy

K. Badani, J. McKiernan, M. Benson, 2011, BJU international.

Active surveillance for renal cortical neoplasms.

K. Badani, J. McKiernan, M. Benson, 2010, The Journal of urology.

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression

J. McKiernan, M. Benson, C. Abate-Shen, 2013, Oncotarget.

Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

M. Desai, J. McKiernan, M. Benson, 2008, Urology.

156 NATIONWIDE PRACTICE PATTERNS FOR THE USE OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AMONG MEN UNDERGOING RADICAL PROSTATECTOMY

A. Neugut, A. Weinberg, M. Benson, 2013 .

A single‐institution experience with induction and maintenance intravesical docetaxel in the management of non‐muscle‐invasive bladder cancer refractory to bacille Calmette‐Guérin therapy

J. McKiernan, M. Benson, L. Barlow, 2009, BJU international.

Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy.

M. Desai, J. McKiernan, M. Benson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1571: Adjuvant Intravesical Therapy and Improved Survival Among Elderly Patients with Superficial Bladder Cancer

A. Neugut, M. Benson, S. Mohile, 2007 .

Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.

M. Benson, K. Ring, F. Karp, 1990, Journal of Occupational Medicine.

Management of urethral recurrence after radical cystectomy and neobladder creation by urethroscopic resection and fulguration.

M. Benson, M. I. Miller, 1996, The Journal of urology.

Treatment options for upper tract transitional-cell carcinoma.

M. Benson, K. Slawin, E. Seaman, 1993, The Urologic clinics of North America.

The Ileal Ureter Neobladder is Associated with a High Success and a Low Complication Rate

M. Benson, C. Olsson, E. Seaman, 1996 .

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.

C. Cordon-Cardo, M. Mansukhani, J. McKiernan, 2011, The Journal of urology.

Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience.

M. Benson, C. Olsson, A. De la taille, 2000, Urology.

Predictive significance of surgical margin status after prostatectomy for prostate cancer during PSA era.

J. McKiernan, M. Benson, G. Decastro, 2008, Urology.

Biopsy and Pathological Predictors of Outcome redictive Significance of Surgical Margin tatus After Prostatectomy for Prostate ancer During PSA Era

M. Desai, J. McKiernan, M. Benson, 2022 .

The necessity of a second prostate biopsy cannot be predicted by PSA or PSA derivatives (density or free:total ratio) in men with prior negative prostatic biopsies.

M. Benson, A. De la taille, E. Bagiella, 1999, Current opinion in urology.

Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy.

M. Rubin, M. Benson, D. Petrylak, 2001, Urologic oncology.

The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy

M. Desai, J. McKiernan, M. Benson, 2011, BJU international.

DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.

Jing Shen, Gregory W Hruby, J. McKiernan, 2012, DNA and cell biology.

Prospective Correlation between Likelihood of Favorable Pathology on the 17‐Gene Genomic Prostate Score and Actual Pathological Outcomes at Radical Prostatectomy

K. Badani, J. McKiernan, M. Benson, 2016, Urology practice.

Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer

A. Neugut, B. Zacharia, M. Benson, 2014, Supportive Care in Cancer.

The impact of regional anesthesia on bladder cancer outcomes.

J. McKiernan, M. Benson, G. Hruby, 2012 .

Flow cytometry in carcinoma of the prostate.

M. Benson, K. Ring, J. Giella, 1990, The Urologic clinics of North America.

PSA updated: still relevant in the new millennium?

J. McKiernan, M. Benson, J. Shah, 2005, European urology.

Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.

N. Lee, M. Benson, C. Olsson, 1999, Urology.

Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.

J. McKiernan, M. Benson, T. McCann, 2008, Urology.

Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.

N. Lee, M. Benson, C. Olsson, 2000, International journal of radiation oncology, biology, physics.

Re‐evaluation of the Tumour‐Node‐Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a)

J. McKiernan, M. Benson, C. Olsson, 2005, BJU international.

ncreasing Detection Rate f Benign Renal Tumors : Evaluation f Factors Predicting for Benign Tumor istologic Features During Past Two Decades

J. McKiernan, M. Benson, L. Murphy, 2022 .

Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis

J. McKiernan, M. Benson, L. Barlow, 2010, BJU international.

Pathological outcome and biochemical recurrence‐free survival after radical prostatectomy in African‐American, Afro‐Caribbean (Jamaican) and Caucasian‐American men: an international comparison

J. McKiernan, M. Benson, G. Hruby, 2013, BJU international.

Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.

K. Badani, A. Roychoudhury, J. McKiernan, 2014, Journal of endourology.

Who really benefits from nephron-sparing surgery?

A. Weinberg, A. Roychoudhury, J. McKiernan, 2014, Urology.

Findings of routine apical margin biopsy during robot-assisted radical prostatectomy.

K. Badani, M. Benson, G. Hruby, 2013, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Does year of radical prostatectomy independently predict outcome in prostate cancer?

J. McKiernan, M. Benson, C. Olsson, 2006, Urology.

Cryoablation for clinically localized prostate cancer using an argon‐based system: complication rates and biochemical recurrence

A. Shabsigh, M. Benson, C. Olsson, 2000, BJU international.

Gleason score concordance on biopsy‐confirmed prostate cancer: is pathological re‐evaluation necessary prior to radical prostatectomy?

K. Badani, M. Benson, S. Sartori, 2011, BJU international.

Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression.

J. McKiernan, M. Benson, J. RiChard, 2012, The Journal of urology.

Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.

J. Lam, M. Benson, E. Goluboff, 2003, The Journal of urology.

529: Prostate Cancer Specific Survival in High Risk Localized Prostate Cancer: How High Risk is High Risk?

J. McKiernan, M. Benson, C. Olsson, 2006 .

Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.

M. Loda, M. Rubin, H. Klocker, 2023, European urology.

Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome.

M. Benson, M. Grossman, M. Benson, 1993, Journal of the American Academy of Dermatology.

The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.

J. McKiernan, M. Benson, L. Barlow, 2016, The Journal of urology.

Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American population

J. McKiernan, M. Benson, S. Gilbert, 2002, Current urology reports.

Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma

J. McKiernan, M. Benson, S. Poon, 2009, BJU international.

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression

J. McKiernan, M. Benson, C. Abate-Shen, 2013, OncoTarget.

Complementary and alternative medicine: the role of the cancer center.

A. Neugut, M. Benson, J. Jacobson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhanced Reverse Transcriptase Polymerase Chain Reaction for Prostate-specific Antigen Combined With Needle Biopsy Results: A Superior Predictor of pT3 Disease.

Katz, M. Rubin, M. Stifelman, 1997, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

M. Desai, J. McKiernan, M. Benson, 2008, Urology.

Active surveillance for renal cortical neoplasms.

K. Badani, J. McKiernan, M. Benson, 2010, The Journal of urology.

A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy.

A. Roychoudhury, J. McKiernan, M. Benson, 2016, Urology.